Literature DB >> 3010612

Arachidonic acid in psoriasis. Pathogenic role and pharmacological regulation.

K Kragballe, J J Voorhees.   

Abstract

AA and its derivatives are a family of potent mediators and regulators of inflammation. There are several pieces of evidence to suggest a pathophysiologic role of certain AA derivatives in psoriasis. The complexity of the pathways in the generation of LTs and other LO products suggests that carefully designed systems will be needed to establish the exact role of these compounds in the pathogenesis of diseases such as psoriasis, and to test the effects of pharmacological inhibitors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3010612

Source DB:  PubMed          Journal:  Acta Derm Venereol Suppl (Stockh)        ISSN: 0365-8341


  3 in total

1.  Biochemical and pharmacological properties of a new topical anti-inflammatory compound, 9-phenylnonanohydroxamic acid (BMY 30094).

Authors:  K M Tramposch; F C Zusi; S A Marathe; P L Stanley; X Nair; S A Steiner; J W Quigley
Journal:  Agents Actions       Date:  1990-06

2.  A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Rapid improvement of clinical manifestations and changes in neutrophil leukotriene profile.

Authors:  F Grimminger; P Mayser; C Papavassilis; M Thomas; E Schlotzer; K U Heuer; D Führer; K D Hinsch; D Walmrath; W B Schill
Journal:  Clin Investig       Date:  1993-08

3.  Combination of a dual 5-lipoxygenase/cyclooxygenase inhibitor with a glucocorticoid results in synergistic topical antiinflammatory activity without inducing skin atrophy.

Authors:  K M Tramposch
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.